Conversation with The Cancer LetterFreeHealth Equity Racial, ethnic minorities are systemically underrepresented in leadership teams across NCI cancer centers June 25, 2021Vol.47 No.25By Matthew Bin Han Ong
Conversation with The Cancer Letter COTA’s Miruna Sasu: I left pharma to “turn the spigot on” in the real-world data industry June 11, 2021Vol.47 No.23By Matthew Bin Han Ong
Conversation with The Cancer Letter Cheryl Willman named head of Mayo Clinic Cancer Programs, director of cancer center May 21, 2021Vol.47 No.20By Paul Goldberg
Conversation with The Cancer LetterReal-world Evidence Here’s something for the Bidens and ARPA-H to do: Build a national, federated ecosystem for digital health, MITRE proposes May 21, 2021Vol.47 No.20By Matthew Bin Han Ong
Conversation with The Cancer Letter St. Jude’s $11.5B, six-year plan aims to improve global outcomes for children with cancer and catastrophic diseases May 14, 2021Vol.47 No.19By Matthew Bin Han Ong
Conversation with The Cancer LetterFilm & TV “1001cuts”—A GYN oncologist examines the toll of sexism in the OR May 14, 2021Vol.47 No.19By Alexandria Carolan
Conversation with The Cancer LetterFree Hinrichs reflects on his move from NCI to Rutgers Cancer Immunology and Metabolism Center of Excellence May 07, 2021Vol.47 No.18By Paul Goldberg
Conversation with The Cancer LetterFree We ask FDA to explain “dangling” accelerated approvals—and this week’s ODAC agenda April 30, 2021Vol.47 No.17By Paul Goldberg
Conversation with The Cancer Letter We ask MIT’s Vander Heiden to delineate science from engineering—and NCI from ARPA-H“The lines are much more blurred in terms of what’s an engineering problem and what’s a basic science problem.” April 23, 2021Vol.47 No.16By Matthew Bin Han Ong and Paul Goldberg
Conversation with The Cancer LetterFree Karen Knudsen named CEO of the American Cancer Society April 12, 2021Vol.47 No.15By Paul Goldberg
